RandyW Posted October 12, 2009 Share Posted October 12, 2009 Pfizer Halts Enrollment in Cancer-Drug Trial * Article * Comments (6) more in Business » BY PETER LOFTUS Pfizer Inc. temporarily halted enrollment of new patients in a clinical trial of an experimental lung-cancer drug, saying the drug was associated with a higher rate of adverse events, including fatalities, than for patients who didn't get the drug. The drug, figitumumab, was in a Phase III, or late-stage, trial in patients with a form of the disease known as nonadenocarcinoma, nonsmall-cell lung cancer. The trial began around March of last year and was projected to have about 820 patients before ending in 2011, according to a U.S. government clinical-trial database. Some of the patients were given figitumumab, also known ... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.